Mark Eisner - Sep 30, 2022 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role
Chief Medical Officer
Signature
/s/ Cecelia Monoarfa-Taime, Attorney-in-Fact
Stock symbol
FGEN
Transactions as of
Sep 30, 2022
Transactions value $
-$88,169
Form type
4
Date filed
10/4/2022, 05:21 PM
Previous filing
Sep 2, 2022
Next filing
Dec 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FGEN Common Stock Tax liability -$88.2K -6.78K -4.55% $13.01* 142K Sep 30, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.